bioRxiv Science⌕ Search

Biology subjects

Tellez, R. C.

Publications and source records attributed to Tellez, R. C..

3 recordsLinked to original sources

Fast and sensitive multiplexed diagnostic system enabled by real-time solid-phase PCR assay

Simultaneous identification of multiple nucleic acid targets is pivotal for high-throughput analysis in clinical diagnostics. Unfortunately, conventional PCR offers limited multiplexing capability due to issues like primer interference, fluorescence spectral overlaps and instrumentation complexity. Solid-phase PCR (SP-PCR), in which primers are physically separated on a solid support, has emerged as an alternative strategy for detection of multiple targets in parallel. However, SP-PCR has been suffering from low efficiency, long reaction time, inability for real-time signal monitoring and accurate quantification, which greatly restricts their applications in multiplexed assays. In this study, we presented for the first time a compact and portable flow-through SP-PCR platform to permit rapid, highly efficient and quantitative solid-phase amplification. We designed an integrated platform comprising a novel mechanically actuated valving system and a dual-chamber SP-PCR system to enable automated sample purification and amplification. Active oscillating the PCR solution between the chambers significantly enhanced the mass diffusion over the solid-phase array. Moreover, after each amplification cycle, the PCR solution was separated from the solid-phase-bound probes, thereby eliminating background signal interference and allowing for real-time monitoring of SP-PCR signals without the need for complex optical systems. The flow-through SP-PCR system demonstrated quantitative detection of five viral pathogens in a single reaction, with a limit of detection of 10 copies per reaction within 20 minutes. This platform provides a promising high-throughput, low-cost and simple-instrumentation multiplexed diagnostic system.

molecular biology↗

Enzymatic Assembly for CRISPR Split-Cas9 System: The Emergence of a Sortase-based Split-Cas9 Technology

CRISPR-Cas9 has been widely used in scientific research and medical investigations as a pioneering technology. However, challenges such as the large size of the Cas9 sequence and potential off-target effects have impeded its widespread adoption. In response, various alternatives, such as split-Cas9 technology, have emerged. Split-Cas9 systems allow the large Cas9 sequence to be divided into two segments to aid in the delivery of the enzyme. Nevertheless, challenges persist in achieving precise control over the timing and location of Cas9 reassembly and activity to minimize off-target effects. This study presents an enzymatic-based split-Cas9 system, introducing a new approach utilizing the Sortase enzyme for the reconstitution of the full Cas9 protein. The developed method eliminates the need for chemical or physical induction and allows for precise genome editing in specific cells through the utilization of various specific promoters or targeted drug delivery. Experimental validation of the enzymatic system was conducted in E. coli, HEK cells, and Jurkat cells, demonstrating successful assembly and activity of the assembled Cas9 enzyme. In addition, this study explored the incorporation of nuclear localization signals, the evaluation of inducible promoters, and the delivery of the systems components in mRNA or protein form. Furthermore, we investigated the potential of S/MAR minicircle technology instead of viral vectors within the system. Overall, we highlighted the feasibility and utility of the Sortase-based split-Cas9 system to enhance control and efficiency compared to traditional CRISPR-Cas9 approaches. Additionally, this study revealed the potential of using the Sortase enzyme for posttranslational modifications and protein assembly in human cells.

molecular biology↗

Metabolic Engineering on a 3D-Printed Microfluidic Platform: A New Approach for Modular Co-Metabolic pathways

Metabolic engineering of cell factories often requires extensive modification of host cellular machinery, leading to numerous challenges such as metabolic burden, intermediate metabolite toxicity, and inadequate endogenous fluxes. To overcome the limitations, we presented an innovative approach for metabolic engineering, by constructing modular biosynthetic pathways on a 3D-printed microfluidic platform. Several new techniques have been developed, including novel designs of chip configurations, effective methods for enzyme immobilization on printed resins, and proper ways to regenerate cofactors in redox reactions. As a proof of concept, we built xylose consumption and CO2 fixation pathways in the microfluidic chips and successfully demonstrated that the platform was able to convert xylose and enable the rapid growth of Saccharomyces cerevisiae, which otherwise will not grow with xylose as the only carbon source. Overall, the 3D-printed microfluidic platform presents a much simpler and more efficient cell-free strategy for developing modular, optimized biosynthetic pathways.

bioengineering↗